The Influenza Vaccines Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The Influenza Vaccines Global Market Report 2024 has demonstrated a robust growth trend. The market, which was valued at $7.35 billion in 2024, is projected to increase to $7.9 billion in 2025. This represents a Compound Annual Growth Rate (CAGR) of 7.5%.
The Influenza Vaccines Global Market Report 2024 predicts that by 2029, the market size for influenza vaccines will be $11.02 billion with a compound annual growth rate (CAGR) of 8.7%.
Download Your Free Sample of the 2025 Influenza Vaccines Market Report and Uncover Key Trends Now!The key drivers in the influenza vaccines market are:
• Climate and environmental factors influencing influenza spread
• Improved accessibility of healthcare services
• Emergence of new strains of influenza
• Innovations in vaccine adjuvants and delivery systems
The influenza vaccines market covered in this report is segmented –
1) By Vaccine Type: Inactivated, Live Attenuated
2) By Valency: Quadrivalent, Trivalent
3) By Route Of Administration: Injection, Nasal Spray
4) By Age Group: Pediatric, Adult
5) By Distribution Channel: Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels
The key trends in the influenza vaccines market are:
• Wider usage of mRNA vaccine technology is becoming a prominent trend.
• There is an intensified focus on pediatric immunization.
• Enhanced measures for seasonal influenza control are on the rise.
• Tailored vaccination strategies and improved vaccination coverage in developing nations are emerging trends.
The major players in the influenza vaccines market are:
• Pfizer Inc
North America was the largest region in the influenza vaccines market in 2024